Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Birnbaum

Showing results (151-160 of 301) with videos related to

Pageof 31
Sort By:
Genes, Chromosomes & Cancer|May 12, 2005
ETV6 gene rearrangements in invasive breast carcinomaAnne Letessier, Christophe Ginestier, Emmanuelle Charafe-Jauffret, et al.
International Journal of Cancer|November 29, 2011
Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinomaColette Charpin, Fattaneh Tavassoli, Véronique Secq, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarraysSophie Giusiano, Claude Cochet, Odile Filhol, et al.
Cancer Research|March 23, 2005
Gene expression profiling identifies molecular subtypes of inflammatory breast cancerFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Oncotarget|March 31, 2016
Comparative genomic analysis of primary tumors and metastases in breast cancerFrançois Bertucci, Pascal Finetti, Arnaud Guille, et al.
BMC Medicine|September 21, 2017
A 25-gene classifier predicts overall survival in resectable pancreatic cancerDavid J Birnbaum, Pascal Finetti, Alexia Lopresti, et al.
The Journal of Pathology|March 3, 2004
Comparative multi-methodological measurement of ERBB2 status in breast cancerChristophe Ginestier, Emmanuelle Charafe-Jauffret, Frédérique Penault-Llorca, et al.
BMC Cancer|August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemiasJulien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
BMC Cancer|January 31, 2008
Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherinAzza Ben Hamida, Intidhar S Labidi, Karima Mrad, et al.
Oncogene|June 26, 2002
Gene expression profiling defines molecular subtypes of classical Hodgkin's diseaseElisabeth Devilard, François Bertucci, Pascal Trempat, et al.
Pageof 31

Showing results (151-160 of 301) with videos related to

Sort By:
Pageof 31
Genes, Chromosomes & Cancer|May 12, 2005
ETV6 gene rearrangements in invasive breast carcinomaAnne Letessier, Christophe Ginestier, Emmanuelle Charafe-Jauffret, et al.
International Journal of Cancer|November 29, 2011
Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinomaColette Charpin, Fattaneh Tavassoli, Véronique Secq, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarraysSophie Giusiano, Claude Cochet, Odile Filhol, et al.
Cancer Research|March 23, 2005
Gene expression profiling identifies molecular subtypes of inflammatory breast cancerFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Oncotarget|March 31, 2016
Comparative genomic analysis of primary tumors and metastases in breast cancerFrançois Bertucci, Pascal Finetti, Arnaud Guille, et al.
BMC Medicine|September 21, 2017
A 25-gene classifier predicts overall survival in resectable pancreatic cancerDavid J Birnbaum, Pascal Finetti, Alexia Lopresti, et al.
The Journal of Pathology|March 3, 2004
Comparative multi-methodological measurement of ERBB2 status in breast cancerChristophe Ginestier, Emmanuelle Charafe-Jauffret, Frédérique Penault-Llorca, et al.
BMC Cancer|August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemiasJulien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
BMC Cancer|January 31, 2008
Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherinAzza Ben Hamida, Intidhar S Labidi, Karima Mrad, et al.
Oncogene|June 26, 2002
Gene expression profiling defines molecular subtypes of classical Hodgkin's diseaseElisabeth Devilard, François Bertucci, Pascal Trempat, et al.
Pageof 31